Post Trial Access Drug Supply Duration Between Visits

  • This topic has 0 replies, 1 voice, and was last updated 1 week, 1 day ago by Anonymous.
Viewing 1 post (of 1 total)
Back to topics
June 8, 2026

Post Trial Access Drug Supply Duration Between Visits

As patients transition from Open-Label Extension into the Post-Trial Access program, can we continue to dispense the same quantity of drug provided during the OLE, equivalent to a 16-week supply between visits/cycles?

I would like to confirm whether maintaining the current 16-week dispensing interval is acceptable for these patients as they roll over to into Post-Trial Access.

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.